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ABSTRACT
OBJECTIVE: To evaluate the occurrence and factors associated with multimorbidity among 
Brazilians aged 50 years and over.
METHODS: This is a cross-sectional study in a nation-based cohort of the non-institutionalized 
population in Brazil. Data were collected between 2015 and 2016. Multimorbidity was 
assessed from a list of 19 morbidities, which were categorized into ≥ 2 and ≥ 3 diseases. The 
analysis included the calculation of frequencies and the most frequent 10 pairs and triplets 
of combinations of diseases. The crude and adjusted analyses evaluated the demographic, 
socioeconomic, behavioral, and contextual variables (area of residence, geopolitical region, and 
coverage of the Family Health Strategy) using Poisson regression.
RESULTS: From the total of 9,412 individuals, 67.8% (95%CI 65.6–69.9) and 47.1% (95%CI 
44.8–49.4) showed ≥ 2 and ≥ 3 diseases, respectively. In the adjusted analysis, women, older 
persons, and those who did not consume alcohol had increased multimorbidity. There were 
no associations with race, area of residence, geopolitical region, and coverage of the Family 
Health Strategy. The 10 pairs (frequencies observed between 11.6% and 23.2%) and the 10 triplets 
(frequencies observed between 4.9% and 9.5%) of the most frequent diseases mostly included 
back problems (15 times) and systemic arterial hypertension (11 times). All combinations were 
statistically higher than expected by chance.
CONCLUSIONS: The occurrence of multimorbidity was high even among younger individuals 
(50 to 59 years). Approximately two in three (≥ 2 diseases) and one in two (≥ 3 diseases) individuals 
aged 50 years and over presented multimorbidity, which represents 26 and 18 million persons 
in Brazil, respectively. We observed high frequencies of combinations of morbidities. 
DESCRIPTORS: Aged. Multimorbidity. Comorbidity. Health Surveys.
Correspondence: 
Bruno P. Nunes  
Rua Gomes Carneiro, 1 - Centro 
96010-610 Pelotas, RS, Brasil 
E-mail: nunesbp@gmail.com
Received: Dec 19, 2017
Approved: Apr 17, 2018
How to cite: Nunes BP, Batista 
SRR, Bof de Andrade F, Souza-
Junior PRB, Lima-Costa MF, 
Facchini LA. Multimorbidity: The 
Brazilian Longitudinal Study of 
Aging (ELSI-Brazil). Rev Saude 
Publica. 2018;52 Supl 2:10s
Copyright: This is an open-access 
article distributed under the 
terms of the Creative Commons 
Attribution License, which permits 
unrestricted use, distribution, and 
reproduction in any medium, 
provided that the original author 
and source are credited.
http://www.rsp.fsp.usp.br/
2s
Multimorbidity: ELSI-Brazil Nunes BP et al.
https://doi.org/10.11606/S1518-8787.2018052000637
INTRODUCTION
Multimorbidity is the simultaneous occurrence of health problems in the same person, 
usually operationalized by the occurrence of ≥ 2 and ≥ 3 chronic diseases1–3. Recent studies 
have shown that multimorbidity is frequent in the world population and affects at least more 
than half of the older population1,4. It is an important public health problem because of its 
high frequency, especially because of its association with mortality, functional decline, and 
low quality of life, in addition to the difficulty of adequate management by health services5–8. 
Studies in developed countries have shown a direct relation between socioeconomic 
indicators and prevalence of multimorbidity, which explains its relevance in the occurrence 
and maintenance of health inequities. A Scottish study has found a multimorbidity 
occurrence twice as high in the age group of 45–49 years for poorer individuals (26.8%) 
compared to the richest (13.4%). In addition, multimorbidity increased with age, and it 
reached 64.9% of the individuals aged between 65 and 84 years4.
Evidence of multimorbidity in low- and middle-income countries is still incipient in contrast 
to high-income countries1, despite the rapid increase in scientific research in recent years and 
the literature showing the higher occurrence of chronic diseases (in isolation) in developing 
countries9. In Brazil, despite some studies presenting results on the accumulation of diseases 
and their distribution by sociodemographic characteristics, only one study, carried out in 
a city in the South of Brazil, has evaluated the occurrence of multimorbidity specifically in 
the older population10. The findings showed a high occurrence of the problem in more than 
60% of the population. It is more frequent among women, older persons, those with lower 
socioeconomic status, and those with less education, as well as among residents of areas 
covered by the Family Health Strategy (FHS).
Thus, a better understanding of the epidemiology of multimorbidity is necessary to subsidize 
policies within the Brazilian Unified Health System (SUS). This study aimed to estimate 
the prevalence and examine factors associated with multimorbidity among Brazilian 
individuals aged 50 years and over.
METHODS
This is a cross-sectional study carried out with baseline data from the Brazilian Longitudinal 
Study of Aging (ELSI-Brazil), which was conducted with a national sample representative of 
the non-institutionalized population aged 50 years and over. The baseline study was conducted 
between 2015 and 2016. The sampling of the study was carried out by clusters combining 
the stratification of primary sampling units (municipalities), census tracts, and households. 
The municipalities were allocated in four strata according to population size. The method of 
Lavallée and Hidiroglou11 was used to decide the size and number of municipalities allocated in 
each stratum, which were: 1st) ≤ 26,700 inhabitants in 4,420 municipalities; 2nd) 26,701–135,000 
inhabitants in 951 municipalities; 3rd) 135,001–750,000 inhabitants in 171 municipalities; 
4th) > 750,000 inhabitants in 23 municipalities. For the first three strata, (municipalities up 
to 750,000 inhabitants), the sample was selected in three stages. In the first one, 18, 15, and 14 
municipalities were selected for the first, second, and third strata, respectively. In the second 
stage, eight census tracts were selected in each municipality, and then the households were 
selected in each census tract in the third stage. In the fourth stratum, which included the 
largest municipalities, sample selection was carried out in two stages (1st – 176 census tracts 
were chosen; 2nd – households). Residents of the selected households aged 50 years and over 
were eligible for interviews. The final sample included 10,000 individuals aged 50 years and 
over (9,412 completed the interviews) living in 70 municipalities in different regions of Brazil. 
More details can be found on the research homepagea and in a previous publication12.
The dependent variable was multimorbidity, measured by counting self-reported morbidities 
from a list of 19 diseases [(systemic arterial hypertension (SAH), back problems, high 
a Fundação Oswaldo Cruz. 
Brazilian Longitudinal Study of 
Aging. Rio de Janeiro; c2015 
[cited 2017 Nov 28]. Available 
from: http://elsi.cpqrr.fiocruz.br
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cholesterol, cataract, arthritis or rheumatism, depression, diabetes, osteoporosis, heart 
problem, glaucoma, emphysema, chronic bronchitis or chronic obstructive pulmonary 
disease (COPD), cerebrovascular accident, cancer, asthma, chronic renal failure, diabetic 
retinopathy, macular degeneration, Parkinson’s disease, and Alzheimer’s disease]. All of 
them were measured based on the interviewee’s report of the medical diagnosis of the 
disease: “Has any doctor told you that you have...?” Questions about eye problems (cataract, 
glaucoma, diabetic retinopathy, and macular degeneration) included the specialty of the 
ophthalmologist. More details on the measure can be obtained at the study websitea. 
Multimorbidity was assessed according to two cutoff points: ≥ 2 and ≥ 3 morbidities1,2.
The independent variables included the following: sex (male, female); age in full years (50–59, 
60–69, 70–79, 80 years and over); self-reported race (white, black, brown, yellow and indigenous, 
does not know or no answer); education level in years (zero, 1–4, 5–8, 9 years or more); index of 
household goods in quartiles constructed from the principal component analysis13 based on 
the number of household appliances, vehicles, and domestic workers at home; smoking (never 
smoked, current smoker – smokes daily or less than daily –, former smoker); consumption 
of alcoholic beverages (never, < once per month, ≥ once per month); area of residence (rural, 
urban); geopolitical region (North, Northeast, Southeast, South, Midwest); household covered 
by the Family Health Strategy (no, yes, does not know or no answer).
Data analysis was performed using the Stata program, SE 15.0. We carried out a descriptive 
analysis of the demographic, socioeconomic, behavioral, contextual, and morbidity variables. 
For each morbidity, we calculated the mean number of associated diseases. The general 
description and the description according to the independent variables of the occurrence of ≥ 2 
and ≥ 3 morbidities included the calculation of percentage (%), 95% confidence interval (95%CI), 
and p value by the Pearson chi-square test. We calculated the occurrence of multimorbidity 
excluding SAH and high cholesterol from the list of morbidities. In addition, we performed 
crude and adjusted analyses using Poisson regression to evaluate the association between 
multimorbidity and all independent variables listed above. In these analyses, we obtained 
the prevalence ratios (PR), 95%CI, and p value (Wald test of heterogeneity). Associations that 
presented 95%CI without including nullity (PR = 1.00) and p value < 0.05 were considered 
statistically significant. For adjustment, all variables were considered at the same determination 
level, and we performed the selection by the backward elimination method. Thus, all variables 
were included in the model, excluding those with higher p value (Wald test of heterogeneity). 
Adjustment was performed until no variable with a p value > 0.20 remained in the model. The 
variables with p value > 0.20 are described in Table 4 with information on measures of effects, 
95%CI, and p value of the model containing the variable, before it was excluded. To calculate the 
10 pairs and 10 triplets of the most prevalent morbidities, we calculated the relation between 
the observed (O) and expected (E) values to measure the occurrence of combinations beyond 
that expected by chance14. The expected values were calculated by multiplying the individual 
prevalence of the diseases. The 95%CI of the O/E ratios were obtained through exact binomial 
probability. All analyses considered the sample design.
The ELSI-Brazil was approved by the Research Ethics Committee of the Instituto René Rachou 
of the Oswaldo Cruz Foundation (Protocol 886.754). All participants signed an informed 
consent form before the interviews. All regulatory and legal aspects were fulfilled. 
RESULTS
The final sample consisted of 9,412 individuals, and 54.0% were women and the mean age 
was 62.9 years. Approximately half of the sample was aged between 50 and 59 years and 
7.1% was 80 years and over. More than 80% reported being white or brown. Approximately 
a quarter of the sample had nine or more years of schooling. Over a third (37.3%) consisted 
of former smokers. Most individuals (84.7%) lived in the urban area and the household was 
covered by the FHS (68.9%). Almost half (47.2%) lived in the Southeast region (Table 1). 
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Individuals presented 2.66 morbidities on average. Arterial hypertension (52.2%), back 
problems (40.8%), and high cholesterol (30.5%) were the most frequent conditions, whereas 
macular degeneration (1.5%), Alzheimer’s disease (0.8), and Parkinson’s disease (0.7%) 
presented the lowest frequencies. The mean associated morbidities ranged from 3.5 for SAH 
to 5.9 for diabetic retinopathy (Table 2).
We observed an increase in the number of morbidities according to age. While 17.7% of the 
individuals aged 50–59 years did not present any chronic morbidity, this value decreased 
to 2.7% among those aged 80 years and over. At the other extreme, 5.8% and 11.3% of 
the individuals aged 50–59 and 80 years and over, respectively, presented more than six 
morbidities (Figure).
The prevalence of multimorbidity was 67.8% (95%CI 65.6–69.9) for ≥ 2 and 47.1% (95%CI 
44.8–49.4) for ≥ 3 diseases (both variables with a valid number of 8,848 individuals), and it 
was higher among women (20 percentage points higher for ≥ 3 morbidities), with increasing 
Table 1. Sample description according to independent variables. Brazilian Longitudinal Study of Aging 
(ELSI-Brazil), 2015–2016.
Variable Category n* %
Sex Female 5,314 54.0
Age (years) 50–59 3,980 47.6
60–69 2,875 29.7
70–79 1,782 15.6
80 and over 775 7.1
Race White 3,590 42.7
Black 887 9.7
Brown 4,283 44.7
Yellow/Indigenous 310 2.9
Does not know 342 3.4
Education level (years of study) Zero 1,530 13.3
1–4 3,638 38.2
5–8 1,878 21.6
9 or more 2,304 26.9
Index of goods (quartiles) 1st (lowest) 2,693 25.1
2nd 2,421 24.9
3rd 2,211 25.0
4th (highest) 2,029 25.0
Smoking Never smoked 4,259 45.6
Current smoker 1,604 17.1
Former smoker 3,546 37.3
Consumption of alcoholic beverages Never 6,909 70.9
< once a month 544 6.0
≥ once a month 1,952 23.1
Area of residence Urban 7,935 84.7
Geopolitical region North 743 5.6
Northeast 2,549 24.1
Southeast 3,922 47.2
South 1,278 16.6
Midwest 920 6.6
Household covered by the FHS No 2,358 25.8
Yes 6,487 68.9
Does not know/No answer 567 5.3
Total 9,412 100
FHS: Family Health Strategy
* Number of respondents without weighting.
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age, and among those who never consumed alcoholic beverages. No statistically significant 
differences were detected for the variables of race and FHS coverage (Table 3). When we 
excluded SAH and high cholesterol, the prevalences of ≥ 2 and ≥ 3 diseases were 49.0% (95%CI 
46.7–51.2) and 29.3% (95%CI 27.4–31.2), respectively (data not presented in tables or figures).
In the crude analysis (for ≥ 2 or ≥ 3 morbidities), the variables of sex, age, race, education 
level, index of goods, smoking, and alcohol consumption were significantly associated with 
multimorbidity. After adjustment, women had 1.26 (95%CI 1.22–1.30) and 1.49 (95%CI 1.41–
1.58) times more multimorbidity compared to men for the cutoff points of ≥ 2 and ≥ 3 chronic 
diseases, respectively. In relation to age, the occurrence of ≥ 3 diseases was 66% (95%CI 
50–83) higher among individuals aged 80 years and over compared to those aged between 
50 and 59 years. For ≥ 2 diseases, we observed a low magnitude association for education 
level; individuals with one to four years of schooling had 1.07 (95%CI 1.02–1.12) times more 
Table 2. Description of morbidities and mean associated diseases. Brazilian Longitudinal Study of Aging 
(ELSI-Brazil), 2015–2016.
Morbidities % Mean associated morbidities
Systemic arterial hypertension 52.2 3.5
Back problems 40.8 3.9
High cholesterol 30.5 3.8
Cataract 24.9 4.0
Arthritis or rheumatism 21.0 4.5
Depression 18.6 4.5
Diabetes 15.8 4.2
Osteoporosis 15.8 4.8
Heart problem 11.7 4.8
Glaucoma 8.4 4.5
Emphysema, chronic bronchitis, or COPD 6.0 4.7
Cerebrovascular accident 5.3 4.6
Cancer 5.3 4.2
Asthma 4.9 4.8
Chronic kidney disease 4.5 5.1
Diabetic retinopathy 1.9 5.9
Macular Degeneration 1.5 5.3
Alzheimer’s disease 0.8 5.7
Parkinson’s disease 0.7 4.9
COPD: chronic obstructive pulmonary disease
Figure. Occurrence of number of morbidities according to age group. Brazilian Longitudinal Study of 
Aging (ELSI-Brazil), 2015–2016. 
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multimorbidity than those with no schooling. Respondents belonging to the lower strata of 
the index of goods presented less multimorbidity. Persons in the highest stratum of the index 
had 13% (for ≥ 2) and 12% (for ≥ 3) more multiple diseases than those in the lowest stratum. 
Table 3. Prevalence of multimorbidity according to independent variables. Brazilian Longitudinal Study 
of Aging (ELSI-Brazil), 2015–2016. 
Variable Category
Multimorbidity
≥ 2 ≥ 3
% 95%CI % 95%CI
Sex p < 0.001 p < 0.001
Male 58.9 56.4–61.5 36.2 33.9–38.5
Female 75.5 73.4–77.4 56.5 54.3–58.7
Age (years) p < 0.001 p < 0.001
50–59 58.8 56.1–61.5 37.1 34.5–39.7
60–69 73.4 70.7–75.8 51.6 49.1–54.2
70–79 79.0 75.9–81.7 61.1 57.3–64.7
80 and over 82.4 78.5–85.7 66.7 62.1–71.0
Race p = 0.112 p = 0.167
White 68.5 65.7–71.2 48.4 45.7–51.1
Black 71.4 65.8–76.4 50.1 44.1–56.1
Brown 66.2 63.3–69.0 45.3 42.6–47.9
Yellow/Indigenous 74.1 65.8–80.9 56.7 39.5–53.9
Education level (years of study) p < 0.001 p < 0.001
Zero 68.2 64.2–72.0 50.8 46.6–55.0
1–4 71.9 69.2–74.4 50.4 47.5–53.3
5–8 66.1 63.3–68.9 45.9 42.8–49.0
9 or more 63.2 59.8–66.4 41.4 38.6–44.2
Index of goods (quartiles) p = 0.010 p = 0.012
1st (lowest) 64.0 61.0–67.0 44.6 41.1–48.1
2nd 70.4 67.9–72.7 50.5 47.4–53.6
3rd 69.1 65.3–72.6 48.2 45.2–51.3
4th (highest) 67.7 64.4–70.9 45.0 41.5–48.5
Smoking p < 0.001 p < 0.001
Never smoked 68.4 66.0–70.7 48.2 45.6–50.8
Current smoker 60.1 56.4–63.6 39.1 35.6–42.7
Former smoker 70.6 67.9–73.1 49.4 46.7–52.0
Consumption of alcoholic beverages p < 0.001 p < 0.001
Never 71.3 69.1–73.4 51.4 49.0–53.8
< once a month 63.5 57.9–68.8 43.1 38.1–48.3
≥ once a month 58.5 55.6–61.4 35.3 32.5–38.3
Area of residence p = 0.040 p = 0.083
Rural 63.6 59.2–67.8 43.6 39.8–47.6
Urban 68.8 66.1–70.9 47.7 45.1–50.3
Geopolitical region p = 0.124 p = 0.130
North 64.1 55.2–72.1 43.2 36.9–49.7
Northeast 64.0 61.5–66.5 44.5 31.4–47.7
Southeast 69.1 65.2–72.6 47.1 43.0–51.3
South 70.7 65.7–75.2 51.7 48.0–55.3
Midwest 69.0 63.2–74.2 48.3 42.7–54.0
Household covered by the FHS p = 0.960 p = 0.639
No 67.5 64.0–70.8 46.8 43.7–50.0
Yes 67.9 65.2–70.5 47.0 44.2–49.7
Does not know/No answer 68.0 62.0–73.4 50.1 44.6–55.5
Total 67.8 65.6–69.9 47.1 44.8–49.4
FHS: Family Health Strategy
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For education level and index of goods, we observed no dose-response relationship. Former 
smokers showed a higher occurrence of the outcome, in which it was at least 9% higher than 
those who had never smoked. Alcohol consumption equal to or greater than once a month 
was associated with a lower frequency of multimorbidity – 9% less for ≥ 2 and 17% less for ≥ 3 
diseases compared to individuals who had never consumed these beverages (Table 4). 
The 10 pairs and triplets of the most frequent diseases mostly included back problems (15 
times) and SAH (11 times). For the pairs, we could observe that one in four presented SAH 
and back problems at the same time and one in five had SAH and high cholesterol together. 
For the triplets, practically one in 10 presented SAH, back problems, and high cholesterol 
and SAH, back problems, and associated arthritis or rheumatism. All 10 most prevalent 
pairs and triplets had a higher than expected occurrence by chance (Table 5). 
Table 4. Crude and adjusted analyses* between multimorbidity and independent variables. Brazilian 
Longitudinal Study of Aging (ELSI-Brazil), 2015–2016. 
Variable
Multimorbidity
≥ 2 ≥ 3
Crude 
analysis
Adjusted 
analysis
Crude 
analysis
Adjusted 
analysis
PR 95%CI PR 95%CI PR 95%CI PR 95%CI
Sex (ref: male)
Female 1.28 1.23–1.33 1.26 1.22–1.30 1.56 1.48–1.65 1.49 1.41–1.58
Age (ref: 50–59)
60–69 1.25 1.19–1.31 1.22 1.17–1.28 1.39 1.29–1.50 1.36 1.26–1.46
70–79 1.34 1.27–1.41 1.30 1.23–1.37 1.65 1.51–1.80 1.56 1.43–1.69
80 and over 1.40 1.31–1.50 1.34 1.26–1.43 1.80 1.64–1.97 1.66 1.50–1.83
Race (ref: white)
Black 1.04 0.96–1.14 1.08 0.99–1.17 1.03 0.92–1.16 1.07 0.98–1.18
Brown 0.97 0.93–1.01 1.01 0.97–1.05 0.93 0.88–0.99 0.99 0.93–1.04
Yellow/Indigenous 1.08 0.97–1.21 1.10 0.99–1.21 0.96 0.83–1.12 0.96 0.83–1.12
Education level (ref: zero)
1–4 1.05 1.00–1.11 1.07 1.02–1.12 0.99 0.92–1.07 1.04 0.97–1.12
5–8 0.97 0.91–1.03 1.04 0.98–1.10 0.90 0.82–0.99 1.04 0.95–1.14
9 or more 0.93 0.86–1.00 0.97 0.91–1.05 0.81 0.74–0.90 0.93 0.85–1.03
Index of goods (ref: 1st)
2nd 1.10 1.04–1.16 1.10 1.05–1.15 1.13 1.03–1.24 1.13 1.04–1.24
3rd 1.08 1.01–1.15 1.10 1.04–1.16 1.08 0.99–1.18 1.11 1.02–1.23
4th (highest) 1.06 0.99–1.13 1.13 1.07–1.19 1.01 0.91–1.12 1.12 1.01–1.24
Smoking (ref: never smoked)
Current smoker 0.88 0.83–0.93 0.97 0.92–1.02 0.81 0.75–0.87 0.97 0.90–1.04
Former smoker 1.03 1.00–1.07 1.09 1.06–1.13 1.02 0.98–1.07 1.13 1.08–1.18
Consumption of alcoholic beverages (ref: never)
< once a month 0.89 0.82–0.97 0.93 0.86–1.02 0.84 0.74–0.94 0.92 0.82–1.02
≥ once a month 0.82 0.79–0.86 0.91 0.87–0.95 0.69 0.64–0.74 0.83 0.77–0.89
Area of residence (ref: rural)
Urban 1.08 1.00–1.16 1.05 0.99–1.12 1.09 0.99–1.21 1.09 1.00–1.18
Geopolitical region (ref: North)
Northeast 1.00 0.87–1.15 0.98 0.86–1.11 1.03 0.87–1.22 0.99 0.86–1.14
Southeast 1.08 0.93–1.25 1.04 0.91–1.18 1.09 0.92–1.30 1.04 0.90–1.20
South 1.10 0.95–1.28 1.06 0.92–1.22 1.19 1.01–1.41 1.13 0.97–1.31
Midwest 1.08 0.93–1.25 1.05 0.93–1.19 1.12 0.93–1.34 1.08 0.94–1.24
Household covered by the FHS (ref: no)
Yes 1.01 0.95–1.07 1.01 0.95–1.07 1.00 0.93–1.08 0.98 0.92–1.06
Does not know/No answer 1.01 0.91–1.11 0.98 0.88–1.08 1.07 0.93–1.22 1.01 0.88–1.17
FHS: Family Health Strategy
* Adjustment performed for all independent variables in the table.
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DISCUSSION
The results of the analysis show that the occurrence of multimorbidity was high even in the 
younger age groups. Of the total, two out of three and one in two individuals presented ≥ 
2 and ≥ 3 diseases, respectively, confirming the relevance and extent of multimorbidity in 
the Brazilian older population. Women, older individuals, and those who never consumed 
alcoholic beverages showed the highest prevalence of multimorbidity. In addition, the 10 
pairs and triplets of the most frequent diseases showed the relevance of combinations of 
morbidities of different systems in the organism.
According to data from the last population census, Brazil had approximately 39 million 
individuals aged 50 years and over. It is estimated that approximately 26 and 18 million 
persons have ≥ 2 and ≥ 3 morbidities, respectively. The adequate management of these 
individuals is a complex challenge and it will require the planning and articulation of 
actions from the SUS to meet this demand.
The prevalence found for multimorbidity is similar to that observed in international 
studies. The prevalence of ≥ 2 morbidities in our study was approximately 70%, which is 
similar to the population-based studies included in a systematic review1. A recent article 
included the occurrence of multimorbidity in nine countries, and it covered studies with 
data collection between 2007 and 2012 using the 12 most prevalent chronic conditions. 
The highest frequency of ≥ 2 diseases was observed in Russia (71.9%) and the lowest were 
in China (45.1%) and Ghana (48.3%). When considering the confidence interval of our 
study, the Brazilian findings are the same as those found in Spain, Finland, Poland, and 
Russia15. Thus, an occurrence of multimorbidity in Brazil similar to high-income countries 
can be observed, despite important socioeconomic differences. The demographic and 
epidemiological transition in the country has occurred faster than that observed in other 
Table 5. Occurrence of the 10 pairs and triplets of the most frequent morbidities. Brazilian Longitudinal 
Study of Aging (ELSI-Brazil), 2015–2016.
Pairs and triplets of morbidities
Observed (O) Expected (E)
O/E 95%CI
% %
Pairs
SAH/Back problems 23.2 21.3 1.09 1.06–1.12
SAH/High cholesterol 18.9 15.9 1.19 1.15–1.23
SAH/Cataract 14.8 13.0 1.14 1.09–1.18
Back problems/High cholesterol 14.8 12.4 1.19 1.14–1.24
Back problems/Arthritis or rheumatism 14.5 8.6 1.69 1.62–1.77
Back problems/Cataract 12.0 10.2 1.18 1.13–1.23
SAH/Arthritis or rheumatism 12.3 11.0 1.12 1.07–1.17
Back problems/Osteoporosis 11.2 6.4 1.74 1.65–1.83
SAH/Depression 11.4 9.7 1.17 1.12–1.23
Back problems/Depression 11.6 7.6 1.53 1.46–1.60
Triplets
SAH/Back problems/High cholesterol 9.5 6.5 1.46 1.39–1.54
SAH/Back problems/Arthritis or rheumatism 8.6 4.5 1.93 1.81–2.05
SAH/Back problems/Cataract 7.5 5.3 1.41 1.33–1.49
SAH/Back problems/Depression 7.2 3.4 1.81 1.70–1.93
SAH/Back problems/Osteoporosis 6.7 4.0 1.99 1.85–2.13
Back problems/Arthritis or rheumatism/Osteoporosis 6.5 1.4 4.76 4.32–5.26
Back problems/High cholesterol/Arthritis or rheumatism 5.8 4.0 2.21 2.05–2.39
Back problems/Arthritis or rheumatism/Depression 5.8 2.6 3.63 3.30–3.98
SAH/High cholesterol/Cataract 5.4 1.6 1.36 1.27–1.46
Back problems/Cataract/Arthritis or rheumatism 4.9 2.1 2.28 2.10–2.49
SAH: systemic arterial hypertension
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countries, especially in developed countries. Thus, with the aging of the population, chronic 
non-communicable diseases become highly frequent problems with different negative 
impacts on the health of individuals. This situation challenges Brazilian health managers, 
policy makers, and scientists to improve the living conditions and the health system for 
the care of older adults with multiple needs, going beyond the existing actions to address 
these morbidities16. The comparison of evidence of ≥ 3 diseases with other studies presented 
a pattern similar to that observed for ≥ 2 morbidities.
The methodological differences between multimorbidity studies hinder a comparison with 
the findings. Notwithstanding, the recent efforts to standardize the concept17 and the 
operationalization of the construct1, there is still no universal definition for the evaluation 
of the subject. The difficulty of standardization may be explained given the different existing 
morbidities, the heterogeneous patterns of occurrence of diseases among countries, and the 
variable relevance of acute and chronic conditions in the different contexts. Nonetheless, 
a consensus is needed to improve the understanding of multimorbidity, or at least a 
standardized list of morbidities for each country.
The inclusion of conditions which are not diseases themselves is an important issue to 
be included in this debate. For example, SAH and high cholesterol are commonly used 
conditions to measure multimorbidity1. Nevertheless, both are considered risk factors for 
chronic non-communicable diseases18,19 and tend to inflate the occurrence of multimorbidity 
because of their high frequencies. In our sample, when we excluded SAH and cholesterol from 
the multimorbidity construct, the prevalence of the outcome decreased by approximately 
18 percentage points for both ≥ 2 and ≥ 3 morbidities. Evaluations should be carried out 
regarding the importance and utility of including these conditions in multimorbity analysis.
Among the factors associated with the outcome, the female sex is usually associated with 
the greater occurrence of multiple problems in older adults20. This result is explained by 
the survival bias, since men have a shorter life expectancy, and survivors tend to have 
fewer health problems21. In addition, women are more likely to use health services22, and 
they are thus more likely to be diagnosed with diseases. The association with age may be 
explained by the greater exposure to stressful events throughout life, which compromise 
the physiological balance and facilitate the onset of chronic diseases20.
The greater occurrence of multimorbidity in the strata of higher index of goods diverges, to 
a certain extent, from other Brazilian studies. A national study carried out with adults23 and 
local studies with adults and older adults10,24 have observed similarities in the occurrence of 
the problem according to an inverse pattern or social stratum – economically unfavorable 
individuals presented more multimorbidity. Despite the differences in the used indicators 
of socioeconomic level, this result deserves attention and a more detailed analysis for a 
better understanding of the association. International evidence tends to show a higher 
incidence of diseases in poorer individuals4,20, which confirms the social determination in 
the health-disease process. An explanation for the result of our study is related to the fact 
that individuals from more favorable economic strata have greater access to health services 
and, consequently, are more frequently diagnosed with morbidities. The information on the 
evaluated morbidities was obtained by the interviewee’s report on the medical diagnosis 
of the disease, which is strongly associated with access to health services. In addition, this 
indicator presents an important relation with education level (usually associated with 
multimorbidity, despite the lack of association in the adjusted analysis of our study). We 
observed that individuals from the lowest stratum of the index of goods showed a lower 
occurrence of multiple problems, especially in the adjusted analysis. When we verified the 
variable that most explains this increase in the effect of the index of goods after adjustment 
(data not shown), it is evident that the inclusion of education level in the model increases 
the strength of the association. Education level is an important factor in the understanding 
of older adults about their existing health condition and diseases25. Finally, the result can 
be affected by the lack of fit to the variables of use of services or residual confusion. The 
increased understanding of these relations, including issues related to the use of health 
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services and coverage of care models, may elucidate the observed results, mainly considering 
the important existing regional differences in Brazil.
Former smokers tend to present early health problems26 and, consequently, greater 
occurrence of multimorbidity. In addition, these individuals have a higher risk of death, 
which may explain the association of low magnitude (between 9% to 13% higher in relation 
to those who had never smoked). This result can be explained by the survival bias; survivors 
are healthier, which attenuates the association found.
The lower frequency of multiple problems among individuals who consumed alcoholic 
beverages (one or more times per month) can be explained by the reverse causality bias 
given the cross-sectional evaluation performed in this article. Individuals who reported some 
alcohol consumption may have fewer morbidities or the fact that they have fewer diseases 
could lead to higher alcohol consumption . Thus, it is not yet possible to define temporality 
in the association. Longitudinal assessments of the study, which include incident cases, 
may contribute to assess possible causal relations between these variables.
The pairs and triplets of diseases showed high frequencies of co-occurrence of morbidities 
with emphasis on the presence of SAH and back problems in most combinations. These 
analyses contribute to the creation of protocols and clinical guidelines for the health care 
of older adults. Almost a quarter of the evaluated individuals presented SAH and back 
problems, thus showing that the management of these individuals would need an integral 
analysis to treat the conditions. If physical activity is recommended for  blood pressure 
control, back problems must be also considered, so that the management of one condition 
does not affect other morbidity27. In addition, as we evaluated frequent conditions, these 
morbidities may occur concomitantly because of chance. Thus, we calculated the relation 
between the occurrence observed and the one expected by chance in the pairs and triplets. 
All patients had a ratio greater than one, and this suggests that morbidities have some type 
of relation, whether causal, if one disease or its treatment increases the risk of another, or 
non-causal, if the morbidities have common risk factors14.
The study presents limitations which should be considered. First, multimorbidity was evaluated 
from a list of diseases and the interviewee’s report of medical diagnosis, which has a strong 
relation with access to health services and may reduce the occurrence of multimorbidity in 
less favored socioeconomic groups. Second, the measurement of some diseases by medical 
diagnosis has limitations related to the low sensitivity and specificity of this type of data 
collection25, especially for mental health problems28. New analyses on multimorbidity should 
include measures of morbidity with greater diagnostic ability. In addition, validation studies 
on the measurement of self-reported medical diagnosis should be performed for the clear 
understanding of the diseases which may be included in the multimorbidity construct. Third, 
the cross-sectional analysis hinders the evaluation of some associations, such as between 
smoking and alcohol consumption and multimorbidity, as there may be reverse causality.
The findings on multimorbidity are an important baseline for future longitudinal analyses 
which evaluate the impact of multiple diseases on health outcomes and quality of care29. To 
ensure a better quality of life for Brazilian older adults we need to act under a comprehensive 
health assessment, which, in turn, demands an understanding of the occurrence and impact 
of multimorbidity. The results show high occurrence of multimorbidity and the factors 
associated with the problem. The pairs and triplets identified show the main combinations 
of diseases found in the population aged 50 and over, which can be included in clinical 
guidelines and evaluated in the care provided in the health services.
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